These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 19393252

  • 1. Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of alpha4beta2 nicotinic receptors in rats.
    Spiller K, Xi ZX, Li X, Ashby CR, Callahan PM, Tehim A, Gardner EL.
    Neuropharmacology; 2009 Jul; 57(1):60-6. PubMed ID: 19393252
    [Abstract] [Full Text] [Related]

  • 2. The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: differences in α4β2 nicotinic receptor activation.
    Cunningham CS, McMahon LR.
    Eur J Pharmacol; 2011 Mar 01; 654(1):47-52. PubMed ID: 21172344
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacologic characterization of a nicotine-discriminative stimulus in rhesus monkeys.
    Cunningham CS, Javors MA, McMahon LR.
    J Pharmacol Exp Ther; 2012 Jun 01; 341(3):840-9. PubMed ID: 22438471
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats.
    Biala G, Staniak N, Budzynska B.
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Apr 01; 381(4):361-70. PubMed ID: 20217050
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
    Rollema H, Chambers LK, Coe JW, Glowa J, Hurst RS, Lebel LA, Lu Y, Mansbach RS, Mather RJ, Rovetti CC, Sands SB, Schaeffer E, Schulz DW, Tingley FD, Williams KE.
    Neuropharmacology; 2007 Mar 01; 52(3):985-94. PubMed ID: 17157884
    [Abstract] [Full Text] [Related]

  • 9. The contribution of α4β2 and non-α4β2 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice.
    de Moura FB, McMahon LR.
    Psychopharmacology (Berl); 2017 Mar 01; 234(5):781-792. PubMed ID: 28028600
    [Abstract] [Full Text] [Related]

  • 10. The sensitizing effect of acute nicotine on amphetamine-stimulated behavior and dopamine efflux requires activation of β2 subunit-containing nicotinic acetylcholine receptors and glutamate N-methyl-D-aspartate receptors.
    Kim MN, Jutkiewicz EM, Zhang M, Gnegy ME.
    Neuropharmacology; 2011 Jun 01; 60(7-8):1126-34. PubMed ID: 20971124
    [Abstract] [Full Text] [Related]

  • 11. The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats.
    O'Connor EC, Parker D, Rollema H, Mead AN.
    Psychopharmacology (Berl); 2010 Feb 01; 208(3):365-76. PubMed ID: 19967529
    [Abstract] [Full Text] [Related]

  • 12. Ligands selective for alpha4beta2 but not alpha3beta4 or alpha7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat.
    Smith JW, Mogg A, Tafi E, Peacey E, Pullar IA, Szekeres P, Tricklebank M.
    Psychopharmacology (Berl); 2007 Feb 01; 190(2):157-70. PubMed ID: 17115136
    [Abstract] [Full Text] [Related]

  • 13. The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats.
    Paterson NE, Min W, Hackett A, Lowe D, Hanania T, Caldarone B, Ghavami A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec 01; 34(8):1455-64. PubMed ID: 20708056
    [Abstract] [Full Text] [Related]

  • 14. The smoking cessation drug varenicline improves deficient P20-N40 inhibition in DBA/2 mice.
    Wildeboer-Andrud KM, Stevens KE.
    Pharmacol Biochem Behav; 2011 Nov 01; 100(1):17-24. PubMed ID: 21763340
    [Abstract] [Full Text] [Related]

  • 15. The Serotonin 2C Receptor Agonist Lorcaserin Attenuates Intracranial Self-Stimulation and Blocks the Reward-Enhancing Effects of Nicotine.
    Zeeb FD, Higgins GA, Fletcher PJ.
    ACS Chem Neurosci; 2015 Jul 15; 6(7):1231-40. PubMed ID: 25781911
    [Abstract] [Full Text] [Related]

  • 16. Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α 7-nicotinic acetylcholine receptors.
    Potasiewicz A, Golebiowska J, Popik P, Nikiforuk A.
    J Psychopharmacol; 2018 Dec 03; 33(1):269881118812097. PubMed ID: 30501536
    [Abstract] [Full Text] [Related]

  • 17. A behavioral economic analysis of the value-enhancing effects of nicotine and varenicline and the role of nicotinic acetylcholine receptors in male and female rats.
    Barrett ST, Geary TN, Steiner AN, Bevins RA.
    Behav Pharmacol; 2018 Sep 03; 29(6):493-502. PubMed ID: 29634495
    [Abstract] [Full Text] [Related]

  • 18. Electrophysiological perspectives on the therapeutic use of nicotinic acetylcholine receptor partial agonists.
    Papke RL, Trocmé-Thibierge C, Guendisch D, Al Rubaiy SA, Bloom SA.
    J Pharmacol Exp Ther; 2011 May 03; 337(2):367-79. PubMed ID: 21285282
    [Abstract] [Full Text] [Related]

  • 19. Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors.
    Mihalak KB, Carroll FI, Luetje CW.
    Mol Pharmacol; 2006 Sep 03; 70(3):801-5. PubMed ID: 16766716
    [Abstract] [Full Text] [Related]

  • 20. Varenicline attenuates cue-induced relapse to alcohol, but not nicotine seeking, while reducing inhibitory response control.
    Wouda JA, Riga D, De Vries W, Stegeman M, van Mourik Y, Schetters D, Schoffelmeer AN, Pattij T, De Vries TJ.
    Psychopharmacology (Berl); 2011 Jul 03; 216(2):267-77. PubMed ID: 21331520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.